Physician profile
Sayed A Ali
NPI 1982709903
$387.66
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $24.85 · 2023: $3.08 · 2024: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $113 · Education: $44.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.88 |
| Education | $44.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $143.11 | 2019 | |
| Amgen INC. | $60.15 | 2024 | Krystexxa |
| Medtronic, INC. | $52.73 | 2024 | Onyx Frontier |
| Travere Therapeutics, INC. | $44.09 | 2023-2024 | |
| Daiichi Sankyo INC. | $43.58 | 2019-2020 | |
| Vivus LLC | $24.39 | 2019 | |
| Fresenius USA Marketing, INC. | $19.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sayed Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.